Proveca Ltd
Alison Foster is an experienced professional in the pharmaceutical and nanotechnology sectors, currently holding the position of Early Phase Development Manager at Proveca Ltd since November 2022. Previously, Alison served as Head of Technical - Pre-Clinical at SGS Quay Pharma from August 2013 to November 2022, where responsibilities included technical management and project oversight. As a co-founder and Pharmaceutical Programme Director at IOTA NanoSolutions Limited (January 2007 - June 2013), Alison led business development and project management efforts in nanotechnology. Additionally, Alison held roles at Unilever R&D as a Scientist, contributing to cross-category research, and at the University of Manchester as a Post Doctoral Researcher in medicinal chemistry. Alison earned a PhD in Organofluorine Chemistry and a BSc in Chemistry from the University of Birmingham.
This person is not in any teams
Proveca Ltd
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit froma period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently.Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.